Together with azacitidine or decitabine, or very low-dose cytarabine in newly diagnosed AML aged ≥ 75 a long time or with co-morbidities that preclude using intense induction chemotherapy Acute leukemia is characterized by a immediate boost in the number of immature blood cells. The crowding that final results from these https://directivepublications.org/journal-of-leukemia-research/